US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Regentis Biomaterials Ltd.

4.38

-0.3200-6.81%

Post-market: 4.380.00000.00%16:10 EST

Volume:18.77K

Turnover:82.58K

Market Cap:22.69M

PE:-3.99

High:4.77

Open:4.75

Low:4.04

Close:4.70

52wk High:8.35

52wk Low:4.04

Shares:5.18M

Float Shares:1.25M

Volume Ratio:1.44

T/O Rate:1.50%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.0970

EPS(LYR):1.72

ROE:--

ROA:-256.70%

PB:-0.51

PE(LYR):2.55

Loading ...

Overview Company News Filings

Amex Halt Add Info Lst 4.080000

THOMSON REUTERS

Regentis Biomaterials Taps New CFO/Chief Business Officer as GelrinC Nears EU Launch and Midpoint of U.S. Phase III Trial

Regentis Biomaterials appoints Ori Gon as CFO, CBO

Regentis Biomaterials Expands U.S. Phase III GelrinC Trial Network After Enrollment Surpasses Midpoint

Amex Halt Add Info Lst 4.810000

THOMSON REUTERS

Amex Halt Add Info Lst 5.650000

THOMSON REUTERS

Regentis’ GelrinC Shows Native-Like Cartilage Regeneration in 2-Year MRI Data

Regentis Biomaterials' GelrinC Shows Native-Like Cartilage Regeneration in Knee Repair Clinical Trial

Regentis Biomaterials Ltd trading halted, volatility trading pause

Amex Halt Add Info Lst 6.870000

THOMSON REUTERS

BRIEF-Eli Hazum Resigned As Chief Executive Officer Of Regentis Biomaterials Ltd

Regentis Biomaterials Reports Long-Term Durability of GelrinC in Cartilage Repair Clinical Trial

Regentis Biomaterials Ltd - Appointed Ehud Geller as Chief Executive Officer

THOMSON REUTERS

Regentis Biomaterials Appoints Chairman Ehud Geller as CEO

BRIEF-Regentis Biomaterials Ltd Granted New U.S. Patent

Regentis Biomaterials Granted New U.S. Patent for Off-the-Shelf Regenerative Cartilage Repair Product GelrinC

Regentis Biomaterials Raises $10 Million in IPO

MT Newswires Live

Sector Update: Health Care Stocks Slide Late Afternoon

MT Newswires Live

Stock Track | Regentis Biomaterials Plummets 12.12% Intraday After Weak NYSE American Debut

Regentis Biomaterials Prices IPO at $8 Per Share

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RGNT/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RGNT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RGNT\",,,,,undefined,":{"symbol":"RGNT","market":"US","secType":"STK","nameCN":"Regentis Biomaterials Ltd.","latestPrice":4.38,"timestamp":1770930000000,"preClose":4.7,"halted":0,"volume":18772,"hourTrading":{"tag":"盘后","latestPrice":4.38,"preClose":4.38,"latestTime":"16:10 EST","volume":3,"amount":13.14,"timestamp":1770930604524,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.06808510638297878,"floatShares":1250000,"shares":5179400,"eps":-1.097,"marketStatus":"Not Yet Opened","change":-0.32,"latestTime":"02-12 16:00:00 EST","open":4.75,"high":4.77,"low":4.04,"amount":82578.690835,"amplitude":0.155319,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.097,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770973200000},"marketStatusCode":0,"adr":0,"listingDate":1764824400000,"exchange":"AMEX","adjPreClose":4.7,"preHourTrading":{"tag":"盘前","latestPrice":5.11,"preClose":4.7,"latestTime":"08:48 EST","volume":19,"amount":97.09,"timestamp":1770904085806,"change":0.41,"changeRate":0.087234,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":4.38,"preClose":4.38,"latestTime":"16:10 EST","volume":3,"amount":13.14,"timestamp":1770930604524,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.440697},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RGNT\",,,,,undefined,":{"symbol":"RGNT","floatShares":1250000,"roa":"-256.70%","roe":"--","lyrEps":1.720119,"volumeRatio":1.440697,"shares":5179400,"dividePrice":0,"high":4.77,"amplitude":0.155319,"preClose":4.7,"low":4.04,"week52Low":4.04,"pbRate":"-0.51","week52High":8.35,"institutionHeld":0,"latestPrice":4.38,"eps":-1.097,"divideRate":0,"volume":18772,"delay":0,"ttmEps":-1.097,"open":4.75,"prevYearClose":6.74,"prevWeekClose":4.83,"prevMonthClose":5.8,"prevQuarterClose":6.74,"fiveDayClose":4.81,"twentyDayClose":6.6379,"sixtyDayClose":8},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RGNT\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RGNT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RGNT\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RGNT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RGNT","date":"2026-02-11","current":-3.992707,"percent":0.898305,"low":-9.624274,"twenty":-6.767941,"median":-6.155131,"eighty":-5.339337,"high":11.294138,"avg":-4.738572,"sd":5.496175,"marketCap":23876932},"quantilePoints":[{"date":"2025-09-12","current":11.294138,"twenty":11.294138,"median":11.294138,"eighty":11.294138,"marketCap":54223158},{"date":"2025-09-17","current":11.294138,"twenty":11.294138,"median":11.294138,"eighty":11.294138,"marketCap":54223158},{"date":"2025-11-14","current":-9.624274,"twenty":-1.256909,"median":11.294138,"eighty":11.294138,"marketCap":54223158},{"date":"2025-11-20","current":-9.624274,"twenty":-9.624274,"median":11.294138,"eighty":11.294138,"marketCap":54223158},{"date":"2025-11-26","current":-9.624274,"twenty":-9.624274,"median":-9.624274,"eighty":11.294138,"marketCap":54223158},{"date":"2025-12-05","current":-6.894806,"twenty":-9.624274,"median":-7.354459,"eighty":11.294138,"marketCap":38845335},{"date":"2025-12-12","current":-6.563855,"twenty":-9.624274,"median":-6.89021,"eighty":11.294138,"marketCap":36980758},{"date":"2025-12-19","current":-5.880074,"twenty":-9.624274,"median":-6.600627,"eighty":11.294138,"marketCap":33128337},{"date":"2025-12-26","current":-6.113394,"twenty":-9.624274,"median":-6.527083,"eighty":1.180569,"marketCap":34442863},{"date":"2026-01-02","current":-6.196132,"twenty":-8.716348,"median":-6.3708,"eighty":-5.580196,"marketCap":34909007},{"date":"2026-01-09","current":-6.352414,"twenty":-7.170598,"median":-6.31555,"eighty":-5.626198,"marketCap":35789501},{"date":"2026-01-16","current":-7.078667,"twenty":-7.005123,"median":-6.260483,"eighty":-5.72734,"marketCap":39881210},{"date":"2026-01-23","current":-6.664979,"twenty":-6.894806,"median":-6.333844,"eighty":-5.846096,"marketCap":37550490},{"date":"2026-01-30","current":-5.635354,"twenty":-6.892967,"median":-6.278869,"eighty":-5.846096,"marketCap":31749587},{"date":"2026-02-06","current":-4.421869,"twenty":-6.856195,"median":-6.196132,"eighty":-5.571003,"marketCap":24912808},{"date":"2026-02-11","current":-4.238007,"twenty":-6.767941,"median":-6.155131,"eighty":-5.339337,"marketCap":23876932}],"updateTime":1770943495984},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RGNT\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2611751629","title":"Amex Halt  Add Info Lst 4.080000","url":"https://stock-news.laohu8.com/highlight/detail?id=2611751629","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611751629?lang=en_us&edition=fundamental","pubTime":"2026-02-13 00:55","pubTimestamp":1770915312,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nAQN2LM236:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RGNT"],"gpt_icon":0},{"id":"2609374765","title":"Regentis Biomaterials Taps New CFO/Chief Business Officer as GelrinC Nears EU Launch and Midpoint of U.S. Phase III Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2609374765","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609374765?lang=en_us&edition=fundamental","pubTime":"2026-02-05 19:57","pubTimestamp":1770292666,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials Ltd ( ($RGNT) ) just unveiled an announcement. On February 4, 2026, Regentis Biomaterials appointed Ori Gon as Chief Financia...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/regentis-biomaterials-taps-new-cfo-chief-business-officer-as-gelrinc-nears-eu-launch-and-midpoint-of-u-s-phase-iii-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/regentis-biomaterials-taps-new-cfo-chief-business-officer-as-gelrinc-nears-eu-launch-and-midpoint-of-u-s-phase-iii-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["III","RGNT","BK4156","BK4139","BK4134"],"gpt_icon":0},{"id":"2608536744","title":"Regentis Biomaterials appoints Ori Gon as CFO, CBO","url":"https://stock-news.laohu8.com/highlight/detail?id=2608536744","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608536744?lang=en_us&edition=fundamental","pubTime":"2026-02-04 22:01","pubTimestamp":1770213694,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials (RGNT) announced the appointment of Ori Gon as CFO and CBO. Gon will lead the Company’s commercial and business development a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regentis-biomaterials-appoints-ori-gon-as-cfo-cbo-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regentis-biomaterials-appoints-ori-gon-as-cfo-cbo-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","RGNT"],"gpt_icon":0},{"id":"2607352020","title":"Regentis Biomaterials Expands U.S. Phase III GelrinC Trial Network After Enrollment Surpasses Midpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2607352020","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607352020?lang=en_us&edition=fundamental","pubTime":"2026-01-29 22:41","pubTimestamp":1769697700,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials Ltd ( ($RGNT) ) has shared an update. On January 29, 2026, Regentis Biomaterials announced it is expanding its U.S. clinical ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/regentis-biomaterials-expands-u-s-phase-iii-gelrinc-trial-network-after-enrollment-surpasses-midpoint?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/regentis-biomaterials-expands-u-s-phase-iii-gelrinc-trial-network-after-enrollment-surpasses-midpoint?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RGNT","BK4134","BK4139","III"],"gpt_icon":0},{"id":"2607745396","title":"Amex Halt  Add Info Lst 4.810000","url":"https://stock-news.laohu8.com/highlight/detail?id=2607745396","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607745396?lang=en_us&edition=fundamental","pubTime":"2026-01-29 00:25","pubTimestamp":1769617506,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nAQN2LJNWZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RGNT","BK4139"],"gpt_icon":0},{"id":"2607743281","title":"Amex Halt  Add Info Lst 5.650000","url":"https://stock-news.laohu8.com/highlight/detail?id=2607743281","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607743281?lang=en_us&edition=fundamental","pubTime":"2026-01-29 00:04","pubTimestamp":1769616291,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nAQN2LJNX0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RGNT"],"gpt_icon":0},{"id":"2604117601","title":"Regentis’ GelrinC Shows Native-Like Cartilage Regeneration in 2-Year MRI Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2604117601","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604117601?lang=en_us&edition=fundamental","pubTime":"2026-01-20 22:38","pubTimestamp":1768919898,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials Ltd ( ($RGNT) ) has provided an update. On January 20, 2026, Regentis Biomaterials announced new long-term MRI data from a co...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/regentis-gelrinc-shows-native-like-cartilage-regeneration-in-2-year-mri-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/regentis-gelrinc-shows-native-like-cartilage-regeneration-in-2-year-mri-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RGNT","BK4139"],"gpt_icon":0},{"id":"2604199141","title":"Regentis Biomaterials' GelrinC Shows Native-Like Cartilage Regeneration in Knee Repair Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2604199141","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604199141?lang=en_us&edition=fundamental","pubTime":"2026-01-20 22:09","pubTimestamp":1768918169,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials Ltd. has announced new long-term imaging data from a completed European clinical trial of its GelrinC device for knee cartilage repair. The results, published in the peer-reviewed journal Cartilage, show that patients treated with GelrinC demonstrated regenerated cartilage with internal structural organization closely resembling healthy, native hyaline cartilage after 24 months. The MRI analysis, conducted using validated methodologies accepted by both the U.S. FDA and the European EMA, indicated that the repaired tissue exhibited a layered architecture similar to native cartilage. GelrinC is currently approved for commercialization in Europe with a CE Mark, and a Phase III U.S. FDA study is ongoing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nNDL8WnFZG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RGNT"],"gpt_icon":0},{"id":"2604997703","title":"Regentis Biomaterials Ltd trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2604997703","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604997703?lang=en_us&edition=fundamental","pubTime":"2026-01-17 00:00","pubTimestamp":1768579215,"startTime":"0","endTime":"0","summary":"10:56 EST Regentis Biomaterials (RGNT) Ltd trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regentis-biomaterials-ltd-trading-halted-volatility-trading-pause-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regentis-biomaterials-ltd-trading-halted-volatility-trading-pause-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","RGNT"],"gpt_icon":0},{"id":"2603446997","title":"Amex Halt  Add Info Lst 6.870000","url":"https://stock-news.laohu8.com/highlight/detail?id=2603446997","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603446997?lang=en_us&edition=fundamental","pubTime":"2026-01-16 23:56","pubTimestamp":1768579004,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260116:nAQN2LI30M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RGNT","BK4139"],"gpt_icon":0},{"id":"2601180198","title":"BRIEF-Eli Hazum Resigned As Chief Executive Officer Of Regentis Biomaterials Ltd","url":"https://stock-news.laohu8.com/highlight/detail?id=2601180198","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601180198?lang=en_us&edition=fundamental","pubTime":"2026-01-06 22:13","pubTimestamp":1767708820,"startTime":"0","endTime":"0","summary":"BRIEF-Eli Hazum Resigned As Chief Executive Officer Of Regentis Biomaterials LtdJan 6  - Regentis Biomaterials Ltd RGNT.A:REGENTIS BIOMATERIALS LTD - ON DECEMBER 31, 2025, ELI HAZUM RESIGNED AS CHIEF EXECUTIVE OFFICER OF REGENTIS BIOMATERIALS LTDREGENTIS BIOMATERIALS LTD - APPOINTED EHUD GELLER AS CHIEF EXECUTIVE OFFICERSource text: [ID:n0001213900-26-001588]Further company coverage: RGNT.A ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nFWN3Y70CF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGNT","BK4139"],"gpt_icon":0},{"id":"2601818826","title":"Regentis Biomaterials Reports Long-Term Durability of GelrinC in Cartilage Repair Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2601818826","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601818826?lang=en_us&edition=fundamental","pubTime":"2026-01-06 21:51","pubTimestamp":1767707490,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials Ltd. has announced the publication of long-term follow-up results from its Phase II clinical trial of GelrinC, a regenerative medicine device for cartilage repair. The study results, published in the peer-reviewed journal Cartilage, demonstrate durable cartilage regeneration at 24 months, as assessed by the MOCART  MRI-based quantitative measure. GelrinC is currently being evaluated in a pivotal Phase III U.S. FDA investigational device exemption  study, with enrollment ongoing and over 50% of patients recruited. The Phase III study is designed to support a future premarket approval  submission.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regentis Biomaterials Ltd. published the original content used to generat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nNDL123RHX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RGNT"],"gpt_icon":0},{"id":"2601897446","title":"Regentis Biomaterials Ltd - Appointed Ehud Geller as Chief Executive Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2601897446","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601897446?lang=en_us&edition=fundamental","pubTime":"2026-01-06 21:09","pubTimestamp":1767704984,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nFWN3Y70CF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RGNT","BK4139"],"gpt_icon":0},{"id":"2601389717","title":"Regentis Biomaterials Appoints Chairman Ehud Geller as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2601389717","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601389717?lang=en_us&edition=fundamental","pubTime":"2026-01-06 21:09","pubTimestamp":1767704946,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials Ltd. announced that Dr. Eli Hazum has resigned as Chief Executive Officer, effective immediately, citing personal reasons. Dr. Ehud Geller, Chairman of the board, has been appointed as the new CEO.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regentis Biomaterials Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 06, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nNDL9zlfMk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RGNT"],"gpt_icon":0},{"id":"2592990728","title":"BRIEF-Regentis Biomaterials Ltd Granted New U.S. Patent","url":"https://stock-news.laohu8.com/highlight/detail?id=2592990728","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592990728?lang=en_us&edition=fundamental","pubTime":"2025-12-18 23:18","pubTimestamp":1766071123,"startTime":"0","endTime":"0","summary":"BRIEF-Regentis Biomaterials Ltd Granted New U.S. Patent Dec 18  - Regentis Biomaterials Ltd RGNT.A:REGENTIS BIOMATERIALS LTD: GRANTED NEW U.S. PATENT FOR OFF-THE-SHELF REGENERATIVE CARTILAGE REPAIR PRODUCT GELRINCSource text: [ID:n0001213900-25-123065]Further company coverage: RGNT.A ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nFWN3XO0Q6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RGNT"],"gpt_icon":0},{"id":"2592018079","title":"Regentis Biomaterials Granted New U.S. Patent for Off-the-Shelf Regenerative Cartilage Repair Product GelrinC","url":"https://stock-news.laohu8.com/highlight/detail?id=2592018079","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592018079?lang=en_us&edition=fundamental","pubTime":"2025-12-18 21:49","pubTimestamp":1766065760,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials Ltd. has been granted a new U.S. patent for its off-the-shelf regenerative cartilage repair product, GelrinC. The patent covers a ready-to-use liquid formulation of GelrinC and improved production processes that avoid the use of organic solvents. This innovation aims to simplify procedures for surgeons, enabling a cartilage repair process that takes approximately 10 minutes. The patent provides protection through 2038, with the potential for further extensions tied to future developments. GelrinC is currently undergoing a pivotal FDA trial and has received regulatory approval in the EU.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regentis Biomaterials Ltd. published the original content used to generate this ne","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nNDL8lSfQC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RGNT"],"gpt_icon":0},{"id":"2589281093","title":"Regentis Biomaterials Raises $10 Million in IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2589281093","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589281093?lang=en_us&edition=fundamental","pubTime":"2025-12-06 05:33","pubTimestamp":1764970412,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials  closed its initial public offering of 1.25 million ordinary shares at $8 each for $10 million in gross proceeds, the company said Friday.The shares began trading Dec. 4 on the NYSE American under the ticker RGNT.Regentis said it will use the proceeds mainly to advance development of its GelrinC cartilage-repair therapy and for corporate purposes.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RGNT"],"gpt_icon":0},{"id":"2589832065","title":"Sector Update: Health Care Stocks Slide Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2589832065","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589832065?lang=en_us&edition=fundamental","pubTime":"2025-12-05 05:01","pubTimestamp":1764882095,"startTime":"0","endTime":"0","summary":"Health care stocks declined late Thursday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each shedding 0.9%.The iShares Biotechnology ETF (IBB) eased 0.1%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0266013472.USD","BK4566","LU1093756325.SGD","LU0320765489.SGD","BK4581","LABU","BK4585","LU0417517546.SGD","CCRN","LU1093756168.USD","BK7500","HUM","HUM.AU","PHG","LU1983260115.SGD","LU0238689110.USD","LU0070302665.USD","BK4196","BK4588","SG9999014013.SGD","LU0256863811.USD","BK7093","BK4082","IBB","LU0348723411.USD","SG9999014005.SGD","SG9999014021.USD","XLV","BK4533","LU0211331839.USD","BK4154","LU0390134368.USD","RGNT","XBI","LU0170899867.USD","LU0208291251.USD"],"gpt_icon":0},{"id":"1119547190","title":"Stock Track | Regentis Biomaterials Plummets 12.12% Intraday After Weak NYSE American Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1119547190","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119547190?lang=en_us&edition=fundamental","pubTime":"2025-12-05 00:54","pubTimestamp":1764867259,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials Ltd. (RGNT) saw its stock plummet 12.12% intraday on Thursday, following its debut on the NYSE American.The decline came after the company priced its initial public offering at...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["RGNT"],"gpt_icon":0},{"id":"2588007665","title":"Regentis Biomaterials Prices IPO at $8 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2588007665","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588007665?lang=en_us&edition=fundamental","pubTime":"2025-12-04 17:18","pubTimestamp":1764839886,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials said late Wednesday it has priced its initial public offering of about 1.3 million shares at $8 per share for gross proceeds of $10 million.Underwriters have been granted a 45-da","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RGNT"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":21,"code":"91000000","status":"200"}]}}